Bone Marrow TransplantationBone MarrowBone Marrow CellsTransplantation, HomologousBone and BonesGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationAnemia, AplasticBone Marrow DiseasesHematopoietic Stem CellsLeukemiaHematopoietic Stem Cell TransplantationBone Marrow PurgingTransplantation ConditioningBone Marrow ExaminationTransplantation ChimeraBone RemodelingBone Marrow NeoplasmsGraft SurvivalTissue DonorsLiver TransplantationBusulfanHematopoiesisMice, Inbred C57BLHistocompatibility TestingCyclophosphamideHistocompatibilityTransplantation, IsogeneicBone DensityRadiation ChimeraCombined Modality TherapyTime FactorsLeukemia, Myeloid, AcuteRecurrenceColony-Forming Units AssayCell DifferentiationBone ResorptionLeukemia, Myelogenous, Chronic, BCR-ABL PositiveKidney TransplantationTreatment OutcomePrecursor Cell Lymphoblastic Leukemia-LymphomaRemission InductionHematologic NeoplasmsLeukemia, MyeloidBone NeoplasmsImmunosuppressive AgentsFlow CytometryGraft RejectionSurvival AnalysisT-LymphocytesCells, CulturedHepatic Veno-Occlusive DiseaseGraft vs Host ReactionLymphoma, Non-HodgkinStem Cell TransplantationLymphocyte DepletionImmunosuppressionTransplantation ImmunologyMyelodysplastic SyndromesAcute DiseaseRetrospective StudiesMice, Inbred BALB CChimeraAntineoplastic Combined Chemotherapy ProtocolsLeukocyte TransfusionSpleenCell ProliferationSevere Combined ImmunodeficiencyPancytopeniaHematologic DiseasesBone DevelopmentSurvival RateHLA AntigensFollow-Up StudiesHeart TransplantationBone DiseasesAntigens, CD34Multiple MyelomaStromal CellsGranulocyte Colony-Stimulating FactorBreast NeoplasmsLeukocyte CountMice, KnockoutActuarial AnalysisAntineoplastic AgentsPrognosisGranulocytesLymphocyte TransfusionCyclosporineCell DivisionAntibodies, MonoclonalDisease-Free SurvivalCell SeparationCarmustineNeoplasmsApoptosisNuclear FamilyStem CellsCytarabine